DRNA - Dicerna Pharmaceuticals Inc
Previous close
38.22
0 0%
Share volume: 0
Last Updated: Mon 27 Dec 2021 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$38.22
0.00
0.00%
Summary score
30%
Profitability
36%
Dept financing
35%
Liquidity
21%
Performance
26%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-24.49%
Return on assets
-13.52%
Return on sales
0%
Return on invested capital
127.94%
Total debt ratio
38.08%
Debt ratio change over timeo
0.32%
Current Ratio
5.04%
Quick Ratio
0%
Cash Position Ratio
2.03%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.31%
Return on assets
-6.11%
Return on sales
0%
Return on invested capital
18.96%
Total debt ratio
72.39%
Debt ratio change over timeo
2.9%
Current Ratio
2.63%
Quick Ratio
0%
Cash Position Ratio
0.69%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-19.62%
Return on assets
-4.57%
Return on sales
0%
Return on invested capital
15.28%
Total debt ratio
77.86%
Debt ratio change over time
6.06%
Current Ratio
2.63%
Quick Ratio
0%
Cash Position Ratio
0.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-141.76%
Return on assets
-115.98%
Return on sales
0%
Return on invested capital
-3.16%
Total debt ratio
31.72%
Debt ratio change over time
0.32%
Current Ratio
6.6%
Quick Ratio
0%
Cash Position Ratio
1.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DRNA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -24.49% | 0% | 0% | 29.06% |
| Return on assets | -13.52% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 127.94% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 34% |
| Total debt ratio | 38.08% | 0% | 0% | 183.15% |
| Debt ratio change over time | 0.32% | 0% | 0% | 19.02% |
| Dept financing | 6% | 0% | 0% | 50% |
| Current Ratio | 2.63% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.69% | 0% | 0% | 5.68% |
| Liquididy | 38% | 0% | 0% | 70% |
| Short-term ratios | DRNA | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -20.31% | 0% | 0% | -16.12% |
| Return on assets | -6.11% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 18.96% | 0% | 0% | 96.56% |
| Profitability | 30% | 0% | 50% | 25% |
| Total debt ratio | 72.39% | 0% | 0% | 79.61% |
| Debt ratio change over time | 2.9% | 0% | 0% | 0.09% |
| Dept financing | 48% | 0% | 0% | 26% |
| Current Ratio | 2.63% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 0.69% | 0% | 0% | 5.68% |
| Liquididy | 14% | 0% | 0% | 75% |